Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intercure Ltd (NQ: INCR )

3.750 +0.020 (+0.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,007
Open 3.684
Bid (Size) 3.690 (1)
Ask (Size) 3.890 (1)
Prev. Close 3.730
Today's Range 3.684 - 3.860
52wk Range 3.270 - 8.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
InterCure Teams Up Wit Praetorian Global To License, Manufacture And Distribute Cannabis Brand 'Binske'
InterCure Ltd. 
Via Benzinga
InterCure to Participate in Cowen 5th Annual Cannabis Conference
Mr. Rabinovitch is one of the global cannabis senior executives to participate 
From InterCure Ltd.
Via Globe NewsWire

Performance

YTD
+5.63%
+5.63%
1 Month
-6.25%
-6.25%
3 Month
-24.09%
-24.09%
6 Month
-40.94%
-40.94%
1 Year
-40.85%
-40.85%

More News

Read More
InterCure Announces the Withdrawal of a Class Action Lawsuit against it
From InterCure Ltd.
Via Globe NewsWire
Israeli Cannabis Producer Touts Record Q3 Revenue, Gross Profit Increase
Via Benzinga
Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
Via Benzinga
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
From Organigram Holdings Inc.
Via Business Wire
InterCure Hits Record Preliminary Q3 Revenue Of $29M
Via Benzinga
InterCure Q2 2022 Revenue Grows 119%, What About Profit?
Via Benzinga
Clever Leaves 2Q: Neutraceuticals Up, Preparing For Cannabis Flower Exports From Colombia
Via Benzinga
Israel's Marijuana Bubble Bursts: Tel Aviv Stock Exchange Eliminates TA-Cannabis Index, Ending Three-Year High
Via Benzinga
InterCure Reports Record Preliminary Q2 2022 Revenue – More Than Double YoY
Via Benzinga
Clever Leaves To Ship First Export Of Cannabis To Israeli Partner InterCure
Via Benzinga
Cannabis Stocks Struggle Through Q2 2022
Via Talk Markets
Invest In The Future Of Medicine Says Berner, CEO Of Cookies At Benzinga's Psychedelics Capital Conference
Via Benzinga
Cannabis Dispensary Roundup: Cookies' CBD Products Now Available In Austria, Parallel & Texas Original Each Open New Stores
Via Benzinga
InterCure And Berner's Cookies Launch Flagship Retail Location In Vienna, Austria
Via Benzinga
InterCure And Berner's Cookies Launch Flagship Cannabis Pharmacy In Be'er Sheva, Israel
Via Benzinga
InterCure Begins 2022 With Record-Breaking Q1 Financial Results, Up 9% Sequentially From Prior Quarter
Via Benzinga
InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY
Via Benzinga
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results
Via Benzinga
InterCure And Clever Leaves Enter Into International Strategic Partnership
Via Benzinga
Berner: Rapper, Entrepreneur, Social Justice Advocate To Participate In Benzinga Psychedelics Capital Conference
Via Benzinga
Israel Set To Decriminalize Rec Cannabis As More Marijuana Businesses Join The Emerging Market
Via Benzinga
Israel Moves To Normalize CBD, Two-Year Path To Market Expected
Via Benzinga
InterCure Teams Up With Altman Health To Bring CBD To Israel Including Charlotte's Web Branded Products
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.